Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2008
09/25/2008WO2008115852A1 A transfection system for perkinsus species
09/25/2008WO2008115851A2 Rnai therapeutic for respiratory virus infection
09/25/2008WO2008115799A1 Novel gene delivery vectors for human mesenchymal stem cells
09/25/2008WO2008115708A1 Methods for the separation of biological molecules using sulfolane
09/25/2008WO2008115632A2 Method for recombining dna sequences and compositions related thereto
09/25/2008WO2008115525A2 Metal-binding therapeutic peptides
09/25/2008WO2008115487A1 Methods of affecting plant growth with microrna
09/25/2008WO2008115387A2 Screening, diagnosing, treating and prognosis of pathophysiologic states by rna regulation
09/25/2008WO2008115296A2 Modified phage for displaying post-translationally modified proteins and uses thereof
09/25/2008WO2008115061A2 Dual targeting system
09/25/2008WO2008115054A2 A method for regulating eukaryotic gene expression at the level of chromatin
09/25/2008WO2008114892A1 Reductase, gene thereof and method of using the same
09/25/2008WO2008114891A1 Reductase, gene thereof and method of using the same
09/25/2008WO2008114876A1 A method of treating malignant mesothelioma
09/25/2008WO2008114856A1 Method for of transcription-degradation dual regulation for protein by antibiotic
09/25/2008WO2008114733A1 Anti-claudin-4 antibody
09/25/2008WO2008114721A1 Microorganism capable of producing l-glutamic acid-type amino acid, and method for production of amino acid
09/25/2008WO2008114709A1 Biomarker specific to blood cell or specific to osteoclast differentiation
09/25/2008WO2008114673A1 Method for production of polypeptide
09/25/2008WO2008114672A1 Cancer-specific biomarker
09/25/2008WO2008114544A1 Probe for visualizing cell cycle
09/25/2008WO2008114501A1 Diagnostic agent and therapeutic agent for cancer
09/25/2008WO2008114497A1 Gene associated with foam formation of acetic acid bacterium, acetic acid bacterium bred by modifying the gene and method for producing vinegar using the acetic acid bacterium
09/25/2008WO2008114145A2 Methods of producing haploid and doubled haploid oil palms
09/25/2008WO2008114020A2 Mutant g-protein coupled receptors and methods for selecting them
09/25/2008WO2008113983A2 Cancer cell specific promoter comprising nf-kappa b binding sites
09/25/2008WO2008113870A1 Method for the diagnosis and/or prognosis of cancer of the bladder
09/25/2008WO2008113847A2 Improved method for homologous recombination
09/25/2008WO2008113832A2 SHORT RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF TARGET mRNA
09/25/2008WO2008113830A1 Rna antagonist compounds for the inhibition of apo-b100 expression
09/25/2008WO2008113773A2 Gene expression regulation technology and noncoding rnas for diagnosis and therapy
09/25/2008WO2008113536A1 Neurotrophic peptides
09/25/2008WO2008113185A1 Antagonists of ligands and uses thereof
09/25/2008WO2008113174A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same
09/25/2008WO2008113163A1 Transgenic expression of acyl-co-a binding proteins in plants
09/25/2008WO2008113145A1 Proteins from the webs of nephilengys cruentata, avicularia juruensis and parawixia bistriata spiders
09/25/2008WO2008098239A3 Paramyxovirus family inhibitors and methods of use thereof
09/25/2008WO2008092935A3 Plants having enhanced yield-related traits and/or increased abiotic stress resistance, and a method for making the same
09/25/2008WO2008092016A3 Methods, compositions, and kits for detection of micro rna
09/25/2008WO2008085605A3 Backbone-free low transgene copy transgenic plants
09/25/2008WO2008084319A3 Novel nucleic acid
09/25/2008WO2008083949A3 Rna-coded antibody
09/25/2008WO2008080505B1 Novel specific arabinose transporter from the yeast pichia stipitis, and uses thereof
09/25/2008WO2008079412A3 Methods and compositions to treat arrhythmias
09/25/2008WO2008077397A3 Method and means for concentrating, removing, and detecting gram-positive bacteria
09/25/2008WO2008073201A3 Compositions and methods for identifying agents that alter expression of survivin
09/25/2008WO2008072713A9 Method of estimating secondary structure in rna and program and apparatus therefor
09/25/2008WO2008071726A3 Pathogen inducible plant trehalose-6-phophate phophatase gene promoters and regulatory elements
09/25/2008WO2008070370A9 Oligonucleotides for use in allele-specific pcr
09/25/2008WO2008066776A3 Methods for treating hypercholesterolemia
09/25/2008WO2008061153A3 Generation of plants with altered protein, fiber, or oil content
09/25/2008WO2008048348A3 Broad spectrum antiviral compositions
09/25/2008WO2008043753A3 Rna antagonist compounds for the modulation of pcsk9
09/25/2008WO2007149406A8 Modified coagulation factor ix polypeptides and use thereof for treatment
09/25/2008WO2007112011A3 Compositions and methods for generating transgenic animals
09/25/2008WO2007087420A8 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof
09/25/2008WO2006031870A3 Strain independent amplification of pathogens and vaccines thereto
09/25/2008WO2006023869A8 Adenylate translocator protein gene non-coding regulatory elements for use in plants
09/25/2008US20080235831 Promoter molecules for use in plants
09/25/2008US20080235830 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars
09/25/2008US20080235829 Comprises an expression vector coding transactivator protein ZmMYB-IF35 for generating plants such as sorghum and maize which have modified flavonoids expression/concentrations
09/25/2008US20080235828 controllable expression; stably introducing said nucleotide molecule into the genome of a recipient cell from a seed-producing plant;culturing said recipient cell into a whole recipient plant
09/25/2008US20080235827 suppressing the shade-avoidance response of plants and improving plant yield; early flowering 3 (ELF3) maize gene; Arabidopsis basic helix-loop-helix transcription factor; expression or overexpression of the ELF3 gene in plants and downregulation of the bHLH-041 gene
09/25/2008US20080235826 useful in the production of dwarf plants; type 5 serine/threonine protein phosphatase activity; production of plants sensitive to light signal transduction
09/25/2008US20080235825 Methods and means for modulating cellulose biosynthesis in fiber producing
09/25/2008US20080235824 Expression results esterases that resists growth inhibitory and/or lethal effects of nonionic, fatty acid ester detergents such as Tween 20 or Span 20; allowing exposed plant cells to regenerate into whole plants in presence of these detergents, providing practical, safe method for plant transformation
09/25/2008US20080235823 An isolated nucleic acid molecule that drives and modulates plant transcription having the nucleotide sequence of SEQ ID NO: 2 operably linked to a heterologous nucleic acid sequence; improves root response to varying water conditions, soil environment, tolerance to pests and food nutrition
09/25/2008US20080235822 Nucleic acids encoding chimeric polypeptides allowing expression of plant-noxious proteins
09/25/2008US20080235821 Nucleotide sequences encoding ramosa3 and sister of ramosa3 and methods of use for same
09/25/2008US20080235819 Plants and seeds of corn variety ex7834
09/25/2008US20080235817 Artificial mammalian chromosome
09/25/2008US20080235816 Multiple inducible gene regulation system
09/25/2008US20080235815 Generating transgenic avians via transformation of urogenital systems for use in expression of heterologous genes; bioreactors
09/25/2008US20080235814 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom
09/25/2008US20080235813 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells
09/25/2008US20080234941 Method of Designing Sirnas for Gene Silencing
09/25/2008US20080234471 Dna sequence; open-reading frame; genetic engineering
09/25/2008US20080234470 Kcnb: a novel potassium channel protein
09/25/2008US20080234469 Binding to monoclonal antibodies; antitumor agents
09/25/2008US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product
09/25/2008US20080234465 Expression in filamentous fungi of protease inhibitors and variants thereof
09/25/2008US20080234264 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
09/25/2008US20080234222 Polylysine and polyethylenimine complex of a therapeutic nucleic acid, a polycationic block copolymer, and a polyanionic block copolymer; dosage form for delivering the nucleic acid to a cell in vivo
09/25/2008US20080234221 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents
09/25/2008US20080234220 Reducing flavivirus or Hepatitis virus replication in vitro or vivo by inhibiting activity of a microRNA; administering an antisense oligonucleotide complementary to microR-122
09/25/2008US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures
09/25/2008US20080234218 Sirna For Inhibiting Il-6 Expression and Composition Containing Them
09/25/2008US20080234217 Double stranded nucleotide sequences for use as tools in tissue targeted gene expression inhibition and treatment of cancer, vascular, neuronal and endocrine diseases
09/25/2008US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor
09/25/2008US20080234215 DNA composition and uses thereof
09/25/2008US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
09/25/2008US20080234212 siRNA molecules which target the transcription factor STAT6 and repress the expression of STAT6 mRNA, STAT6 protein and STAT6 function in lung cells
09/25/2008US20080234201 BH3 peptides and method of use thereof
09/25/2008US20080234191 Depleting complement; treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation; increasing the efficiency and/or effectiveness of gene therapy; may be chemically linked to an antibody with an affinity for a specific tissue
09/25/2008US20080234187 In particular amidated, acetylated, phosphorylated and/or glycosylated derivatives; diagnostic agents including a nucleic acid or messenger RNA coding for the cytokine; isolated from human hemofiltrate
09/25/2008US20080234184 These membrane domains are of viral envelope proteins that allow viruses to anchor to the target cells that they will infect; allows coexpression of the TME1 and TME2 membrane domains of the hepatitis C virus envelope proteins
09/25/2008US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer.
09/25/2008US20080234176 Modified peptides and their uses
09/25/2008US20080234142 Random Mutagenesis And Amplification Of Nucleic Acid
09/25/2008US20080234130 Compositions providing tolerance to multiple herbicides and methods of use thereof